部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,273 | 100.0% | 1,773 | 100.0% | 1,500 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 289 | 8.8% | 199 | 11.2% | 90 | 6.0% |
食道 | C15 | 232 | 7.1% | 200 | 11.3% | 32 | 2.1% |
胃 | C16 | 217 | 6.6% | 168 | 9.5% | 49 | 3.3% |
大腸 | C18-C21 | 163 | 5.0% | 94 | 5.3% | 69 | 4.6% |
( 結腸 ) | C18 | 89 | 2.7% | 50 | 2.8% | 39 | 2.6% |
( 直腸S状結腸移行部、直腸 、肛門及び肛門管 ) | C19-C21 | 74 | 2.3% | 44 | 2.5% | 30 | 2.0% |
膵 | C25 | 142 | 4.3% | 86 | 4.9% | 56 | 3.7% |
気管、気管支及び肺 | C33-C34 | 220 | 6.7% | 160 | 9.0% | 60 | 4.0% |
血液、骨髄 | C420 C421 | 115 | 3.5% | 67 | 3.8% | 48 | 3.2% |
皮膚(黒色腫以外) | C44 | 110 | 3.4% | 57 | 3.2% | 53 | 3.5% |
乳房 | C50 | 307 | 9.4% | 0 | 0.0% | 307 | 20.5% |
子宮 | C53-C55 | 221 | 6.8% | - | - | 221 | 14.7% |
( 子宮頚 ) | C53 | 134 | 4.1% | - | - | 134 | 8.9% |
( 子宮体部 ) | C54 | 87 | 2.7% | - | - | 87 | 5.8% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 226 | 6.9% | 226 | 12.7% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 177 | 5.4% | 94 | 5.3% | 83 | 5.5% |
悪性リンパ腫 | M959-M972 | 169 | 5.2% | 87 | 4.9% | 82 | 5.5% |
その他(100件未満) | 685 | 20.9% | 335 | 18.9% | 350 | 23.3% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 98.6% | 100.0% | 60.0% | 31.6% | 66.7% | 0.0% | 89.0% |
手術 | 34.3% | 100.0% | 60.0% | 31.6% | 33.3% | 0.0% | 35.4% |
(うち、体腔鏡的治療) | 28.6% | 0.0% | 20.0% | 0.0% | 16.7% | 0.0% | 24.4% |
内視鏡的治療 | 72.1% | 0.0% | 0.0% | 0.0% | 33.3% | 0.0% | 59.9% |
放射線療法 | 0.7% | 0.0% | 0.0% | 5.3% | 0.0% | 0.0% | 1.2% |
化学療法 | 1.4% | 50.0% | 40.0% | 63.2% | 0.0% | 0.0% | 9.9% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 100.0% | 100.0% | 100.0% | 64.3% | 75.0% | 0.0% | 92.0% |
手術 | 16.7% | 85.7% | 100.0% | 100.0% | 64.3% | 50.0% | 0.0% | 69.3% |
(うち、体腔鏡的治療) | 5.6% | 53.6% | 23.1% | 10.0% | 35.7% | 0.0% | 0.0% | 28.4% |
内視鏡的治療 | 83.3% | 17.9% | 0.0% | 0.0% | 0.0% | 25.0% | 0.0% | 23.9% |
放射線療法 | 0.0% | 0.0% | 7.7% | 10.0% | 14.3% | 0.0% | 0.0% | 4.5% |
化学療法 | 0.0% | 3.6% | 30.8% | 30.0% | 50.0% | 0.0% | 0.0% | 17.0% |
その他 | 0.0% | 0.0% | 0.0% | 0.0% | 7.1% | 0.0% | 0.0% | 1.1% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 38.9% | 53.8% | 53.3% | 0.0% | 0.0% | 75.0% | 45.1% |
手術 | 38.9% | 53.8% | 40.0% | 0.0% | 0.0% | 75.0% | 42.2% |
(うち、体腔鏡的治療) | 5.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% |
内視鏡的治療 | 0.0% | 0.0% | 13.3% | 0.0% | 0.0% | 0.0% | 2.8% |
放射線療法 | 2.8% | 7.7% | 6.7% | 33.3% | 0.0% | 0.0% | 5.6% |
化学療法 | 16.7% | 23.1% | 40.0% | 66.7% | 0.0% | 50.0% | 26.8% |
TAE | 47.2% | 38.5% | 13.3% | 0.0% | 0.0% | 0.0% | 33.8% |
レーザー等治療 | 22.2% | 7.7% | 0.0% | 0.0% | 0.0% | 0.0% | 12.7% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 70.9% | 45.0% | 9.7% | 0.0% | 50.0% | 100.0% | 39.1% |
手術 | 70.9% | 45.0% | 9.7% | 0.0% | 50.0% | 100.0% | 39.1% |
(うち、体腔鏡的治療) | 67.1% | 40.0% | 9.7% | 0.0% | 50.0% | 0.0% | 36.3% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 0.6% |
放射線療法 | 24.1% | 55.0% | 61.3% | 39.1% | 0.0% | 100.0% | 38.0% |
化学療法 | 6.3% | 10.0% | 67.7% | 67.4% | 0.0% | 0.0% | 33.0% |
レーザー等治療 | 2.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% |
その他 | 0.0% | 0.0% | 0.0% | 4.3% | 0.0% | 0.0% | 1.1% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 95.7% | 91.7% | 69.2% | 22.2% | 0.0% | 100.0% | 89.1% |
放射線療法 | 60.5% | 31.9% | 58.3% | 61.5% | 22.2% | 0.0% | 100.0% | 48.2% |
化学療法 | 4.7% | 23.4% | 54.2% | 92.3% | 77.8% | 0.0% | 100.0% | 33.6% |
内分泌療法 | 41.9% | 59.6% | 50.0% | 46.2% | 22.2% | 0.0% | 0.0% | 48.2% |
(重複あり)